Zhaoke Ophthalmology Limited
Zhaoke Ophthalmology Limited, an ophthalmic pharmaceutical company, engages in the research, development, manufacture, and commercialization of therapies that address unmet medical needs in the People's Republic of China, South Korea, Hong Kong, and internationally. It develops various drugs that cover ophthalmic indications, including dry eye disease, myopia, presbyopia, wet age-related macular … Read more
Market Cap & Net Worth: Zhaoke Ophthalmology Limited (9FX)
Zhaoke Ophthalmology Limited (F:9FX) has a market capitalization of $189.48 Million (€184.60 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #17424 globally and #1814 in its home market, demonstrating a -3.98% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Zhaoke Ophthalmology Limited's stock price €0.34 by its total outstanding shares 546139172 (546.14 Million).
Zhaoke Ophthalmology Limited Market Cap History: 2026 to 2026
Zhaoke Ophthalmology Limited's market capitalization history from 2026 to 2026. Data shows growth from $189.48 Million to $189.48 Million (0.00% CAGR).
Zhaoke Ophthalmology Limited Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Zhaoke Ophthalmology Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 9FX by Market Capitalization
Companies near Zhaoke Ophthalmology Limited in the global market cap rankings as of March 19, 2026.
Key companies related to Zhaoke Ophthalmology Limited by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #165 globally with a market cap of $114.33 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #285 globally with a market cap of $73.32 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #340 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #497 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #165 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $114.33 Billion | $451.59 |
| #285 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $73.32 Billion | $744.12 |
| #340 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #497 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Zhaoke Ophthalmology Limited Historical Marketcap From 2026 to 2026
Between 2026 and today, Zhaoke Ophthalmology Limited's market cap moved from $189.48 Million to $ 189.48 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €189.48 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Zhaoke Ophthalmology Limited was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $189.48 Million USD |
| MoneyControl | $189.48 Million USD |
| MarketWatch | $189.48 Million USD |
| marketcap.company | $189.48 Million USD |
| Reuters | $189.48 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.